MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Congress Gets Along on User Fee Reauthorization

Related Content:
Massachusetts Congressman Calls for 510(k) Reform Provisions in User Fee Act

Congress is being praised for its bipartisan efforts in its markup of the user fee reauthorization. The current user fee program will expire in September.

AdvaMed seems happy with this week's developments, as president and CEO Stephen Ubl stated, "Mark up is an important milestone in the reauthorization process, and we are encouraged by the bipartisan support this legislation has received."

"The user fee agreement recently reached between the agency and the medical technology industry is a potential game-changer that could help accelerate the development and approval of safe and effective treatments and diagnostics," Ubl stated in an association release.

Maria Fontanazza is managing editor at UBM Canon. Follow her on Twitter @MariaFontanazza.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.